FI45180C - Menetelmä terapeuttisesti arvokkaiden sulfonanilidien valmistamiseksi. - Google Patents

Menetelmä terapeuttisesti arvokkaiden sulfonanilidien valmistamiseksi.

Info

Publication number
FI45180C
FI45180C FI133465A FI133465A FI45180C FI 45180 C FI45180 C FI 45180C FI 133465 A FI133465 A FI 133465A FI 133465 A FI133465 A FI 133465A FI 45180 C FI45180 C FI 45180C
Authority
FI
Finland
Prior art keywords
sulfonanilides
preparation
therapeutically valuable
valuable
therapeutically
Prior art date
Application number
FI133465A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI45180B (fr
Inventor
Larsen Aubrey Arnold
Uloth Robert Henry
Original Assignee
Mead Johnson & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR977261A external-priority patent/FR4290M/fr
Priority claimed from US439086A external-priority patent/US3341584A/en
Application filed by Mead Johnson & Co filed Critical Mead Johnson & Co
Application granted granted Critical
Publication of FI45180B publication Critical patent/FI45180B/fi
Publication of FI45180C publication Critical patent/FI45180C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI133465A 1962-01-24 1965-06-04 Menetelmä terapeuttisesti arvokkaiden sulfonanilidien valmistamiseksi. FI45180C (fi)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16849862A 1962-01-24 1962-01-24
US24459762A 1962-12-14 1962-12-14
FR977261A FR4290M (fr) 1964-06-05 1964-06-05
US38550464A 1964-07-27 1964-07-27
US439086A US3341584A (en) 1962-01-24 1965-03-11 Anilides

Publications (2)

Publication Number Publication Date
FI45180B FI45180B (fr) 1971-12-31
FI45180C true FI45180C (fi) 1972-04-10

Family

ID=27515261

Family Applications (1)

Application Number Title Priority Date Filing Date
FI133465A FI45180C (fi) 1962-01-24 1965-06-04 Menetelmä terapeuttisesti arvokkaiden sulfonanilidien valmistamiseksi.

Country Status (10)

Country Link
AT (1) AT285578B (fr)
BE (2) BE647349A (fr)
CH (1) CH558784A (fr)
DE (1) DE1518023A1 (fr)
DK (1) DK135450C (fr)
FI (1) FI45180C (fr)
FR (1) FR152F (fr)
GB (1) GB1108577A (fr)
NL (1) NL143220B (fr)
SE (1) SE353087B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0164865B1 (fr) * 1984-05-04 1988-12-21 The Upjohn Company N-(aminoalcoylphényl)sulfonamides, leur préparation et leur utilisation thérapeutique
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines
SE8705150D0 (sv) * 1987-12-23 1987-12-23 Haessle Ab Novel antiarrhythmic agents
US5360822A (en) * 1990-02-07 1994-11-01 Nippon Shinyaku Co. Ltd. Sulfonanilide derivatives and medicine
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
CA2740952C (fr) 2008-10-22 2015-12-29 Ian L. Scott Composes de traitement de maladies et troubles ophtalmiques
EP4211129A1 (fr) 2020-09-11 2023-07-19 Centre national de la recherche scientifique Échafaudages de thiophèneoxime et de furanoxime

Also Published As

Publication number Publication date
GB1108577A (en) 1968-04-03
NL143220B (nl) 1974-09-16
BE665006A (fr) 1965-12-06
BE647349A (fr) 1964-08-17
DK135450C (da) 1977-09-26
NL6507196A (fr) 1965-12-06
FI45180B (fr) 1971-12-31
FR152F (fr)
AT285578B (de) 1970-11-10
CH558784A (de) 1975-02-14
SE353087B (fr) 1973-01-22
DE1518023A1 (de) 1971-12-23
DK135450B (da) 1977-05-02

Similar Documents

Publication Publication Date Title
FI45970C (fi) Menetelmä terapeuttisesti arvokkaiden 1-substituoitu-2-aryyli-4- tai 5 -nitroimidatsolien valmistamiseksi.
SE300618B (sv) Förfarande för framställning av N-fenylpropyl- N1 -fenylpiperaziner
DK104675C (da) Fremgangsmåde til fremstilling af 3-hydroxy-N-nitro-picolinamid.
FI45180C (fi) Menetelmä terapeuttisesti arvokkaiden sulfonanilidien valmistamiseksi.
FI46507C (fi) Menetelmä uuden terapeuttisesti käytettävän 1-metyyli-N-karbobentsoksi dihydrolysergamiinin valmistamiseksi.
DK115325B (da) Fremgangsmåde til fremstilling af fenylalkylsulfamider.
DK114340B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme gona-4,9-dien-3-oner eller de tilsvarende D-homoforbindelser.
DK111447B (da) Fremgangsmåde til fremstilling af 17α-vinyl-5(10)-østren-17β-ol-3-on.
FI47097C (fi) Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-metyyli-5 -metoksi-3-indolyylietikkahapon valmistamiseksi.
DK103476C (da) Fremgangsmåde til fremstilling af 2-oxa-3-oxo-steroider.
DK124261B (da) Analogifremgangsmåde til fremstilling af tertiære carbamyltriazoler.
FI45954C (fi) Menetelmä terapeuttisesti vaikuttavien bentseenisulfonyylivirtsa-ainei den valmistamiseksi.
DK108915C (da) Fremgangsmåde til fremstilling af 21-acyloxy-acetyloxy-corticosteroider.
DK103512C (da) Fremgangsmåde til fremstilling af 3-nitroso-2-oxazolidon.
FI45047C (fi) Menetelmä terapeuttisesti käytettävän 2-sulfaniiliamido-5-metoksipyrim idiinin valmistamiseksi.
FI46387C (fi) Menetelmä 2,3,5-tri-O-asetyyli-6-atsauridiinin valmistamiseksi.
FI36690A (fi) Förfarande för framställning av 1,1-dialkylcyklohexantrionderivat
DK104063C (da) Fremgangsmåde til fremstilling af 4-hydroxy-5-halogenpyrimidiner.
FI36781A (fi) Förfarande för framställning av partiella xylitfettsyraestrar
IS680B6 (is) Aðferð til framleiðslu 6-desoxy-6-desmethyltetracyclin.
FI41427C (fi) Förfarande för framställning av klordiazepoxidlösning
FI36288A (fi) Förfarande för framställning av tetrahydrodibenzazosiner
FI36450A (fi) Förfarande för framställning av tetrahydrodibenzocyklo-oktenderivat
FI36612A (fi) Förfarande för framställning av tetrahydrodibenzazosin
FI36449A (fi) Förfarande för framställning av dihydrodibenzocyklo-heptenderivat